Search Results
Jun 29, 2026, 15:45 ET Cotton Patch Cafe Enters Next Chapter of Growth Under Local Texas Ownership
continue as Founder and Free-Range Creative of Local Favorite Restaurants, setting the creative and growth vision across the group. Brandon Coleman III, who led Cotton Patch Cafe as CEO, will assume the role of Chief Executive Officer of Local Favorite Restaurants, overseeing its full house of Texas
More news about: Cotton Patch Cafe
Jun 29, 2026, 13:56 ET Smartee met en avant sa technologie de repositionnement mandibulaire et ses solutions d'aligneurs pour le sommeil lors du salon EOS 2026
de Smartee était sa technologie GS de repositionnement mandibulaire, mise au point pour les cas cliniques de malocclusion de classe II et de classe III liés à des problèmes de position de la mandibule.Contrairement aux approches classiques utilisant des gouttières transparentes, qui visent principalement
More news about: Smartee Denti-Technology
Jun 29, 2026, 10:31 ET Nephrotic Syndrome Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Emerging Therapies and Expanding Research | DelveInsight
Developments in the Nephrotic Syndrome MarketIn February 2026, Roche reported positive Phase III results from the MAJESTY trial, the first global Phase III study evaluating GAZYVA (obinutuzumab) in patients with primary membranous nephropathy. In January 2026, Boehringer
More news about: DelveInsight Business Research, LLP
Jun 29, 2026, 10:00 ET Amorepacific Highlights Science-Led K-Beauty Innovation at NYSCC
session highlighted practical applications of these emerging ingredients and featured case studies on recently launched products, including IOPE XMD Stem III Clinical Recovery Serum and Innisfree Retinol Green Tea PDRN™ Firming Serum. A key study finding showed that PDRN nano-liposomes achieved up to 7.8 times
More news about: Amorepacific
Jun 29, 2026, 09:56 ET Smartee präsentiert auf der EOS 2026 Technologien zur Unterkiefer-Repositionierung und Lösungen für Schlaf-Aligner
der Ausstellung von Smartee war die GS-Technologie zur Unterkiefer-Repositionierung, die für klinische Szenarien mit Malokklusionen der Klassen II und III entwickelt wurde, bei denen die Position des Unterkiefers eine Rolle spielt.Im Gegensatz zu herkömmlichen Clear-Aligner-Verfahren, die in erster
More news about: Smartee Denti-Technology
Jun 29, 2026, 09:00 ET At a Turning Point for RAS-directed Therapies, Break Through Cancer and the Lustgarten Foundation Launch New Pancreatic Cancer Initiative
extraordinary challenge pledge of $250 million from Mr. and Mrs. William H. Goodwin, Jr. and their family, and the estate of William Hunter Goodwin III.For further information, please visit the Foundation's website at
More news about: Break Through Cancer
Jun 29, 2026, 08:38 ET Bitmine Immersion Technologies (BMNR) anuncia que sus tenencias de ETH alcanzan los 5,70 millones de tokens
con el respaldo de un grupo selecto de inversores institucionales, entre los que se incluyen Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversor particular Thomas "Tom" Lee, para apoyar el objetivo de Bitmine de adquirir el 5% de ETH
More news about: Bitmine Immersion Technologies, Inc.
Jun 29, 2026, 08:34 ET Smartee destaca su tecnología y soluciones en EOS 2026
de la exposición de Smartee fue su tecnología de reposicionamiento mandibular GS, desarrollada para casos clínicos de maloclusión de clase II y clase III asociados con consideraciones posicionales mandibulares.A diferencia de los alineadores transparentes convencionales, que se centran
More news about: Smartee Denti-Technology
Jun 29, 2026, 08:31 ET Learning Ally Announces National Board Leadership Transition as 80th Anniversary Approaches
helping struggling readers succeed is as important today as it has ever been."A Vision for the FutureLearning Ally CEO Howard Bell, III expressed profound gratitude for Llorente's enduring legacy while welcoming Koken's leadership to guide the nonprofit's expanding reach."Therese's
More news about: Learning Ally
Jun 29, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.70 Million Tokens, and Total Crypto and Total Cash Holdings of $9.8 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: Bitmine Immersion Technologies, Inc.
Jun 29, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.70 Million Tokens, and Total Crypto and Total Cash Holdings of $9.8 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETHNORWALK,
More news about: Bitmine Immersion Technologies, Inc.
Jun 29, 2026, 08:10 ET TAT Technologies Added to Russell 2000® Index
maintenance repair and overhaul ("MRO") services for heat transfer components and OEM of heat transfer solutions through its subsidiary, Limco Airepair Inc.; (iii) MRO services for aviation components through its subsidiary, Piedmont Aviation Component Services LLC (mainly Auxiliary Power Units and landing gear);
More news about: TAT Technologies Ltd
Jun 29, 2026, 08:00 ET Alebund Pharmaceuticals (09637.HK) Debuts on the HKEx Main Board
(CKD) patients on dialysis, with its registrational Phase III trial in China having met the primary endpoint, a New Drug Application (NDA) to the National Medical Products Administration (NMPA) planned for the near future, and its China-U.S. Phase III multi-regional clinical trial (MRCT) having completed
More news about: Alebund Pharmaceuticals
Jun 29, 2026, 08:00 ET OPTICAL CABLE CORPORATION JOINS RUSSELL MICROCAP® INDEX
may include, among other information, (i) statements concerning our outlook for the future, (ii) statements of belief, anticipation or expectation, (iii) future plans, strategies or anticipated events, and (iv) similar information and statements concerning matters that are not historical facts. Such forward-looking
More news about: Optical Cable Corporation
Jun 29, 2026, 08:00 ET Nuvation Bio Announces Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated in the United Kingdom
disease-free survival as determined by investigator, and the primary completion date is estimated to be in 2030. Nuvation Bio is also sponsoring TRUST-III (
More news about: Nuvation Bio Inc.
Jun 29, 2026, 07:30 ET Else Nutrition Announces CSE Conditional Approval
In connection with the conditional listing, the Company is working to complete an additional funding of US$310,000 with Lind Global Fund III LP. Listing on the CSE also remains subject to the approval of the CSE and the satisfaction of customary listing conditions, and there can be no assurance
More news about: Else Nutrition Holdings Inc.
Jun 29, 2026, 07:06 ET Honeywell Aerospace completes spin-off from Honeywell Technologies and begins trading on Nasdaq
attention and the impact on, and possible disruption of, relationships with regulators, customers, suppliers, employees and other business counterparties; (iii) the possibility of disruption, including disputes, litigation or unanticipated costs, in connection with the spin-off transaction; (iv) the uncertainty
More news about: Honeywell Aerospace Inc.
Jun 29, 2026, 07:05 ET REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
the Phase IIb/III NAAVIGATE clinical trial of investigational surabgene lomparvovec (sura-vec, ABBV-RGX-314) in diabetic retinopathy (DR) using suprachoroidal delivery. REGENXBIO will receive $100 million from AbbVie for this milestone."Dosing the first patient in the Phase IIb/III study is a significant
More news about: REGENXBIO Inc.
Jun 29, 2026, 07:00 ET ADMA INVESTOR NOTICE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
ADMA Biologics engaged in an undisclosed related party transaction; (ii) ADMA Biologics used channel stuffing to create an appearance of revenue; and (iii) ADMA Biologics lacked adequate internal controls.On March 24, 2026, Culper Research issued a report entitled "ADMA Biologics Inc (ADMA): Channel
More news about: Robbins Geller Rudman & Dowd LLP
Jun 29, 2026, 07:00 ET Rocket Lab to Acquire Iridium in Historic Deal, Creating A Fully Vertically Integrated Space Powerhouse Primed for Growth
circumstances that could give rise to the termination of the merger agreement, including the receipt by Iridium of an unsolicited proposal from a third party; (iii) failure to realize the anticipated benefits of the proposed transaction on a timely basis or at all, including anticipated tax treatment, unforeseen
More news about: Iridium Communications Inc.
Jun 29, 2026, 07:00 ET Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
including (i) the early stages of clinical development of Talawar's product candidates, (ii) Talawar's reliance on third-party suppliers and manufacturers, (iii) the outcomes of any future collaboration agreements and (iv) Talawar's ability to adequately maintain intellectual property rights for its product candidates,
More news about: Talawar Therapeutics
Jun 29, 2026, 07:00 ET Rocket Lab to Acquire Iridium in Historic Deal, Creating A Fully Vertically Integrated Space Powerhouse Primed for Growth
circumstances that could give rise to the termination of the merger agreement, including the receipt by Iridium of an unsolicited proposal from a third party; (iii) failure to realize the anticipated benefits of the proposed transaction on a timely basis or at all, including anticipated tax treatment, unforeseen
More news about: Iridium Communications Inc.
Jun 29, 2026, 06:34 ET Smartee Highlights Mandibular Repositioning Technology and Sleep Aligner Solutions at EOS 2026
ApproachesA key focus of Smartee's exhibition was its GS Mandibular Repositioning Technology, developed for clinical scenarios involving Class II and Class III malocclusion associated with mandibular positional considerations.Unlike conventional clear aligner approaches that primarily address tooth movement,
More news about: Smartee Denti-Technology
Jun 29, 2026, 06:30 ET HONEYWELL TECHNOLOGIES LAUNCHES AS INDEPENDENT, PURE-PLAY AUTOMATION COMPANY FOLLOWING COMPLETION OF HONEYWELL AEROSPACE SPIN-OFF
the impact on, and possible disruption of, existing relationships with regulators, customers, suppliers, employees and other business counterparties; (iii) the possibility of disruption, including disputes, litigation or unanticipated costs, in connection with the spin-off transaction; (iv) the uncertainty
More news about: Honeywell Technologies
Jun 29, 2026, 06:00 ET Hyperscale Data Establishes Michigan AI Development Reserve Account and Plan to Provide Monthly Michigan AI Infrastructure Progress Reports
through the two five-year extension options, would be expected to result in total contract revenue in excess of $3.0 billion. Milton "Todd" Ault III, Executive Chairman of Hyperscale Data, stated, "The Michigan Campus represents the most significant growth initiatives in our Company's history, and
More news about: Hyperscale Data Inc.